• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非结直肠神经内分泌癌肝转移的外科治疗。

Surgical treatment of liver metastases from non-colorectal non-neuroendocrine carcinomas.

机构信息

Department of General, Visceral and Vascular Surgery, University Hospital Jena, Erlanger Allee 101, 07740, Jena, Germany.

Department of General, Visceral Surgery, Zentralklinik Bad Berka, Robert-Koch-Allee 9, 99438, Bad Berka, Germany.

出版信息

J Cancer Res Clin Oncol. 2022 Feb;148(2):503-515. doi: 10.1007/s00432-021-03631-5. Epub 2021 Apr 20.

DOI:10.1007/s00432-021-03631-5
PMID:33880657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8800927/
Abstract

INTRODUCTION

In the literature, results after surgical treatment of non-colorectal non-neuroendocrine liver metastases (NCNNLM) are reported that are often inferior to those from colorectal liver metastases. The selection of patients with favorable tumor biology is currently still a matter of discussion.

MATERIALS/METHODS: The retrospective data analysis was based on data that were collected for the multicenter study "Role of surgical treatment for non-colorectal liver metastases" in county Thuringia.

RESULTS

For the study, 637 patients were included from 1995 to 2018. 5 and 10-year survival of R0 resected patients were 33% and 19%, respectively. In the multi-variate analysis of the entire group, sex, timing, disease-free interval, number of metastases, R-classification as well as lymph node status of the primary lesion showed an independent statistical influence on the 5-year survival. In the group of R0 resected patients, disease-free interval, number of metastases and lymph node status of the primary lesion influenced the 5-year survival in the multi-variate analysis. In kidney malignancies, R-classification, timing and number of liver metastases were statistically significant in the multi-variate analysis of the 5-year survival, in mamma carcinomas only the R-classification.

CONCLUSION

The Adam score identifies some risk factors which influence prognosis in most but not in all tumor entities. For kidney cancer and breast cancer it can be simplified.

摘要

简介

在文献中,报道的非结直肠神经内分泌肝转移瘤(NCNNLM)的手术治疗结果往往不如结直肠肝转移瘤。目前,选择具有良好肿瘤生物学特性的患者仍然是一个讨论的问题。

材料/方法:这项回顾性数据分析基于在图林根县为多中心研究“非结直肠肝转移的手术治疗作用”而收集的数据。

结果

在这项研究中,1995 年至 2018 年共纳入 637 例患者。R0 切除患者的 5 年和 10 年生存率分别为 33%和 19%。在全组的多变量分析中,性别、时机、无病间期、转移灶数量、R 分类以及原发灶淋巴结状态对 5 年生存率有独立的统计学影响。在 R0 切除患者中,无病间期、转移灶数量和原发灶淋巴结状态在多变量分析中影响 5 年生存率。在肾脏恶性肿瘤中,R 分类、时机和肝转移灶数量在 5 年生存率的多变量分析中具有统计学意义,而在乳腺癌中仅 R 分类具有统计学意义。

结论

Adam 评分确定了一些影响大多数但不是所有肿瘤实体预后的危险因素。对于肾癌和乳腺癌,可以简化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/752c/11800783/23b38c827799/432_2021_3631_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/752c/11800783/996fa381dde0/432_2021_3631_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/752c/11800783/ab335ceb9bc1/432_2021_3631_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/752c/11800783/2ce2c544f730/432_2021_3631_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/752c/11800783/1575eac0eb95/432_2021_3631_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/752c/11800783/23b38c827799/432_2021_3631_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/752c/11800783/996fa381dde0/432_2021_3631_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/752c/11800783/ab335ceb9bc1/432_2021_3631_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/752c/11800783/2ce2c544f730/432_2021_3631_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/752c/11800783/1575eac0eb95/432_2021_3631_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/752c/11800783/23b38c827799/432_2021_3631_Fig5_HTML.jpg

相似文献

1
Surgical treatment of liver metastases from non-colorectal non-neuroendocrine carcinomas.非结直肠神经内分泌癌肝转移的外科治疗。
J Cancer Res Clin Oncol. 2022 Feb;148(2):503-515. doi: 10.1007/s00432-021-03631-5. Epub 2021 Apr 20.
2
Outcomes of 1,639 hepatectomies for non-colorectal non-neuroendocrine liver metastases: a multicenter analysis.1639 例非结直肠非神经内分泌肝转移瘤肝切除术的结果:一项多中心分析。
J Hepatobiliary Pancreat Sci. 2018 Nov;25(11):465-475. doi: 10.1002/jhbp.587. Epub 2018 Nov 20.
3
Laparoscopic liver resection for non-colorectal non-neuroendocrine metastases: perioperative and oncologic outcomes.腹腔镜肝切除术治疗非结直肠非神经内分泌转移瘤:围手术期和肿瘤学结果。
World J Surg Oncol. 2019 Sep 4;17(1):156. doi: 10.1186/s12957-019-1700-y.
4
Hepatectomy for liver metastases in non-colorectal, non-neuroendocrine cancer patients. The survival benefit in primary unresectable cases.非结直肠癌、非神经内分泌癌患者肝转移灶的肝切除术。不可切除原发灶患者的生存获益。
Int J Surg. 2015 Oct;22:136-42. doi: 10.1016/j.ijsu.2015.07.716. Epub 2015 Aug 12.
5
[Liver resection for non-colorectal, non-neuroendocrine liver metastases--is hepatic resection justified as part of the oncosurgical treatment?].[非结直肠癌、非神经内分泌肝转移瘤的肝切除术——肝切除作为肿瘤外科治疗的一部分是否合理?]
Zentralbl Chir. 2009 Sep;134(5):430-6. doi: 10.1055/s-0029-1224601. Epub 2009 Sep 15.
6
[Surgery for non-colorectal and non-neuroendocrine liver metastases].[非结直肠癌和非神经内分泌性肝转移瘤的手术治疗]
Wien Klin Wochenschr. 2001 Sep 17;113(17-18):681-7.
7
[Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].[结直肠癌肝转移肝切除术后长期预后的预后因素]
Chir Ital. 2005 Sep-Oct;57(5):555-70.
8
Colorectal liver metastases: hepatic pedicle clamping during hepatectomy reduces the incidence of tumor recurrence in selected patients. Case-matched analysis.结直肠肝转移:肝门阻断在肝切除术中可降低部分患者肿瘤复发率。病例匹配分析。
Eur J Surg Oncol. 2013 Jul;39(7):726-33. doi: 10.1016/j.ejso.2013.03.015. Epub 2013 Apr 18.
9
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases.结直肠肝肺转移瘤潜在治愈性切除术后辅助全身化疗。
Clin Colorectal Cancer. 2013 Sep;12(3):188-94. doi: 10.1016/j.clcc.2013.04.002. Epub 2013 Jun 14.
10
Is hepatectomy justified for patients with RAS mutant colorectal liver metastases? An analysis of 524 patients undergoing curative liver resection.对于患有RAS突变型结直肠癌肝转移的患者,肝切除术是否合理?对524例行根治性肝切除术的患者进行的分析。
Surgery. 2017 Feb;161(2):332-340. doi: 10.1016/j.surg.2016.07.032. Epub 2016 Aug 31.

引用本文的文献

1
Histopathological growth pattern of liver metastases as an independent marker of metastatic behavior in different primary cancers.肝转移瘤的组织病理学生长模式作为不同原发性癌症转移行为的独立标志物。
Front Oncol. 2023 Oct 27;13:1260880. doi: 10.3389/fonc.2023.1260880. eCollection 2023.

本文引用的文献

1
Surgical resection of synchronous liver metastases in gastric cancer patients. A propensity score-matched study.胃癌患者同步肝转移的手术切除。一项倾向评分匹配研究。
Radiol Oncol. 2020 Nov 10;55(1):57-65. doi: 10.2478/raon-2020-0067.
2
[Surgical treatment of hepato-pancreatic metastases from renal cell carcinoma].[肾细胞癌肝胰转移的外科治疗]
Chirurg. 2021 Oct;92(10):948-954. doi: 10.1007/s00104-020-01331-3. Epub 2021 Jan 4.
3
Evolving Role of Liver Resection in Selected Patients With Metastatic Breast Cancer.肝切除术在选定转移性乳腺癌患者中的作用演变。
J Surg Res. 2021 Mar;259:363-371. doi: 10.1016/j.jss.2020.09.022. Epub 2020 Nov 11.
4
The lack of selection criteria for surgery in patients with non-colorectal non-neuroendocrine liver metastases.非结直肠神经内分泌肝脏转移患者手术选择缺乏标准。
World J Surg Oncol. 2020 May 25;18(1):106. doi: 10.1186/s12957-020-01883-y.
5
Comparison of hepatic resection and systemic treatment of breast cancer liver metastases: A propensity score matching study.乳腺癌肝转移的肝切除术与全身治疗的比较:一项倾向评分匹配研究。
Am J Surg. 2020 Oct;220(4):945-951. doi: 10.1016/j.amjsurg.2020.02.047. Epub 2020 Feb 28.
6
Surgery Strategies for Gastric Cancer With Liver Metastasis.伴有肝转移的胃癌手术策略
Front Oncol. 2019 Dec 6;9:1353. doi: 10.3389/fonc.2019.01353. eCollection 2019.
7
Percutaneous microwave ablation versus surgical resection for ovarian cancer liver metastasis.经皮微波消融与手术切除治疗卵巢癌肝转移的比较。
Int J Hyperthermia. 2020;37(1):28-36. doi: 10.1080/02656736.2019.1706767.
8
Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades.过去四十年来肺癌患者的发病率、治疗情况及生存率趋势。
Cancer Manag Res. 2019 Jan 21;11:943-953. doi: 10.2147/CMAR.S187317. eCollection 2019.
9
The role of hepatectomy for synchronous liver metastases from pancreatic adenocarcinoma.肝切除术在胰腺癌同期肝转移治疗中的作用。
Surg Oncol. 2018 Dec;27(4):688-694. doi: 10.1016/j.suronc.2018.09.004. Epub 2018 Sep 18.
10
Outcome after hepatic resection for isolated non-colorectal, non-neuroendocrine liver metastases in 100 patients - the role of the embryologic origin of the primary tumor.100例孤立性非结直肠癌、非神经内分泌肝转移患者肝切除术后的结局——原发肿瘤胚胎学起源的作用
BMC Surg. 2018 Oct 29;18(1):89. doi: 10.1186/s12893-018-0424-1.